Overview

Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
Comparison of the effect of Atomoxetine and psychoeducation with placebo and psychoeducation after 10 weeks of treatment
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Atomoxetine Hydrochloride